Cannabinoid receptor CB1-immunoreactive nerve fibres in painful and non-painful human tooth pulp

Journal of Clinical Neuroscience

Volumn 17, Issue 11, 2010, Pages 1476-1479

  Beneng, K ^a   Renton, T ^a   Yilmaz, Z ^a   Yiangou, Y ^b   Anand, P ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Cannabinoid 1 receptor; Dental pain; Dental pulp

Indexed keywords

CANNABINOID 1 RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE FIBER; NEUROFILAMENT; ODONTOBLAST; PRIORITY JOURNAL; TOOTH EXTRACTION; TOOTH PAIN; TOOTH PULP;

ADULT; DENTAL PULP; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFILAMENTS; MIDDLE AGED; NEUROFILAMENT PROTEINS; NOCICEPTORS; RECEPTOR, CANNABINOID, CB1; SENSORY RECEPTOR CELLS; TOOTHACHE; YOUNG ADULT;

EID: 77957354336     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2010.04.005     Document Type: Article

References (26)

1. J.H. Nunn The burden of oral ill health for children Arch Dis Child 91 2006 251 253
2. J.A. Lipton, J.A. Ship, and D. Larach-Robinson Estimated prevalence and distribution of reported orofacial pain in the United States J Am Dent Assoc 124 1993 115 121
3. M.R. Byers, and M.V. Narhi Dental injury models. Experimental tools for understanding neuroinflammatory interactions and polymodal nociceptor functions Crit Rev Oral Biol Med 10 1999 4 39
4. v1.8 immunoreactivity in painful human dental pulp BMC Oral Health 5 2005 5
5. A.H. Lichtman, and B.R. Martin Spinal and supraspinal components of cannabinoid-induced antinociception J Pharmacol Exp Ther 258 1991 517 523
6. F.L. Smith, K. Fujimori, and J. Lowe Characterization of 9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats Pharmacol Biochem Behav 60 1998 183 191
7. S.P. Welch, J.W. Huffman, and J. Lowe Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A J Pharmacol Exp Ther 286 1998 1301 1308
8. E. Palazzo, I. Marabese, and V. De Novellis Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception Neuropharmacology 40 2001 319 326 (Pubitemid 32144710)
9. R.G. Pertwee Cannabinoid receptors and pain Prog Neurobiol 63 2001 569 611
10. W.J. Martin, C.M. Loo, and A.I. Basbaum Spinal cannabinoids are anti-allodynic in rats with persistent inflammation Pain 82 1999 199 205
11. J. Li, R.S. Daughters, and C. Bullis The cannabinoid receptor agonist WIN 55, 212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats Pain 81 1999 25 33
12. U. Herzberg, E. Elviav, and G.J. Bennet The analgesic effects of R(+)-WIN 55, 212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain Neurosci Lett 221 1997 157 160
13. Costa B, Comelli F, Colleoni M, et al. Effect of CB1/TRPV1 agonist, arvanil, in acute inflammation and in persistent inflammatory and neuropathic pain. In: XVI symposium on the Cannabinoids, 24-29 June, Hungary; 2006. p. 38.
14. A. Fox, A. Kesingland, and C. Gentry The role of central and peripheral cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain Pain 92 2001 91 100
15. T.P. Malan, M.M. Ibrahim, and T.W. Vanderah Inhibition of pain responses by activation of CB2 cannabinoid receptors Chem Phys Lipids 121 2002 191 200
16. D.R. Sagar, S. Kelly, and P.J. Millns Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats Eur J Neurosci 22 2005 371 379
17. K. Tsou, S. Brown, and C. Sanudo-Pena Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system Neuroscience 38 1998 393 411
18. M. Egertová, and M.R. Elphick Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB J Comp Neurol 422 2000 159 171
19. U. Anand, W.R. Otto, and D. Sanchez-Herrera Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons Pain 138 2008 667 680
20. P. Anand, G. Whiteside, and C.J. Fowler Targeting CB2 receptors and the endocannabinoid system for the treatment of pain Brain Res Rev 60 2009 255 266
21. T.J. Price, G. Helesic, and D. Parghi The neuronal distribution of cannabinoid receptor type-1 in the trigeminal ganglion of the rat Neuroscience 120 2003 155 162
22. M.M. Ibrahim, F. Porreca, and J. Lai CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids Proc Natl Acad Sci USA 102 2005 3093 3098
23. A.M. Patwardhan, A. Diogenes, and K.A. Berg PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor Pain 125 2006 114 124
24. Y.C. Liang, C.C. Huang, and K.S. Hsu The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain Neuropharmacology 53 2007 169 177
25. T.J. Price, A. Patwardhan, and A.N. Akopian Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55, 212-2 on trigeminal sensory neurons Br J Pharmacol 142 2004 257 266
26. D. Bridges, A.S. Rice, and M. Egertová Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry Neuroscience 119 2003 803 812